Imatinib Mesylate in Treating Patients With Myelofibrosis

Clinical trial NCT00039416 · COMPLETED

Trial details

NCT number: NCT00039416
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia Essential Thrombocythemia Polycythemia Vera Primary Myelofibrosis

Start date: 2002-04-01
Primary completion: 2007-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.